Industry NewsQIAGEN receives FDA authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
Industry NewsQIAGEN and GT Molecular collaborate to offer a complete SARS-CoV-2 wastewater detection solution
Industry NewsQIAGEN’s NeuMoDx HAdV Quant Assay secures CE-IVD certification for automated testing to detect human adenovirus infections
Product NewsQIAGEN launches dedicated CRISPR products for rapid and simplified analysis of gene-editing experiments
Product NewsQIAGEN launches first FDA-approved tissue companion diagnostic to identify the KRAS G12C mutation in NSCLC tumours and expand precision medicine options in lung cancer
Industry NewsQIAGEN partners with Mirati Therapeutics to develop KRAS-G12C companion diagnostic for non-small-cell lung cancer
Product NewsQIAGEN receives U.S. FDA Emergency Use Authorization for fast and easy-to-use digital test to detect SARS-CoV-2 coronavirus antibodies
Industry NewsQIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 test offering up to threefold increase in daily lab testing capacity
Product NewsQIAGEN launches the new LIAISON LymeDetect Assay based on QuantiFERON in partnership with DiaSorin
Industry NewsQIAGEN and INOVIO expand collaboration to develop next-generation sequencing companion diagnostic for INOVIO’s VGX-3100